ArticleJournal of cosmetic dermatology2023

Safely use of omalizumab during SARS-CoV-2 infection in patients with chronic spontaneous urticaria.

Öner Özdemir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.